A new alkylamine derivative and a common fatty acid were isolated from Streptomyces sp. YIM 66142. On the basis of spectral data, including HRMS, NMR and 2D NMR, their structures were determined as medelamine C (1) and isomyristic acid (2). The -hydroxyl group in structure 1 is rare in a natural alkylamine. The possible biosynthetic pathway in the genus Streptomyces from isomyristic acid (2) to medelamines is proposed. Compound 1 showed no obvious cytotoxicity against HL-60, SMMC-7721, A-549, MCF-7, SW480 cell lines. The -hydroxyl and the acetyl at NH in compound 1 decreased its cytotoxicity in comparison with that of medelamine.
Endophytic actinobacteria are considered as important natural sources of secondary metabolites. In recent years, there has been increasing interest in the search for antitumor agents from endophytes; many antibiotics have been isolated from plantassociated actinomycetes [1, 2] . Medelamines, novel alkylamine anticancer agents, were first isolated from Streptomyces sp. NK14819 [3] . ω-Hydroxylation of alkylamine derivatives by the microorganism Torulopsis gropengiesseri has been studied [4] . A primary bioactivity screening indicated that the plant endogenous Streptomyces sp. YIM 66142 showed some antibacterial activity against Fusarium avenaceum, with inhibition zones of 12 mm. Therefore a chemical investigation of this strain was carried out and one new, long-chain alkylamine derivative, medelamine C (1), and a common fatty acid, isomyristic acid (2) [5] were isolated from this strain. The possible biosynthetic pathway from compound 2 to medelamines was proposed in this research. The change of structure in compound 1 decreased its cytotoxicity in comparison to that of medelamine.
Compound 1: A molecular formula of C 16 H 33 NO 2 was determined for 1 by HREI-MS and ESI-MS, with m/z: 271.2524 [M] + (Calcd for 271.2511) and 294 [M+Na] + , together with 13 C NMR data, indicating one degree of unsaturation. The 13 C NMR spectrum showed the presence of one carbonyl at  170.3, one quaternary carbon at  71.1, three methyl groups at  23.3, 29.2 and 29.2, and eleven methylenes at  24.2 to 43.9. The correlations in the COSY spectrum from H-1 to H-11 indicated a multiple proton nuclear spin system in the skeleton structure of 1. The HMBC from H-1 and H-2 to C-1 insured that C-2 and NH were connected to C-1, and the HMBC correlations from H-11, H-13 and H-1 to C-12, from H-13, H-1 to C-11 showed that C-11, C-13 and C-1 were connected to C-12. ) 10 ] + also confirmed this stucture. Thus, the structure of 1 was elucidated as medelamine C (1-acetomidotridecan-12-methyl-12-ol), a new natural ω-hydroxyl alkylamine (Figure 1 ). The full assignments of the 1 H and 13 C NMR chemical shifts were obtained mainly by 2D NMR. alkylamines, and as the differences between them are the ω-hydroxyl and acetyl at NH in medelamine C, the steps of biotransformation from isomyristic acid (2) to medelamine C (1) might follow the sequence of amination at the carboxyl, reduction at the carbonyl, and acetylation and hydroxylation at the ω-position (Figure 2 ), because the ω-hydroxylation biotransformation from 1acetamidotetradecan for the acetyl at NH to 1-acetamidotetradecan-13-ol were confirmed in the microorganism [4] . So, the acetylation might happen before hydroxylation in the biosynthetic pathway from medelamine A to compound 1 in streptomycetes ( Figure 2) .
Effects of the carbon chain structures of fatty acids on their cytotoxicity to breast cancer cells were studied, and the results showed that the branched carbon chain structure has some relevance to its cytotoxicity [5] . Medelamine A and 1 have similar branched long-chain structures. However, medelamine A showed cytotoxicity to the normal rat kidney cell line, NRK, with an IC 50 of 2.10 g/mL [3] , but medelamine C (1) showed no obvious cytotoxicity against any of the five tested cell lines. The differences between them were the ω-hydroxyl and acetyl at NH in medelamine C. So, the weaker cytotoxicity of medelamine C might be caused by the ω-hydroxyl and acetyl at NH in structure 1. An assessment of cytotoxicity in the analogues of medelamine, clavaminols A-N was performed. Of these, clavaminol A was cytotoxic, with an IC 50 of 5 g/mL, but clavaminols C and F were completely inactive at the concentrations tested, demonstrating a definite structure-activity relationship for the amino and hydroxyl groups [6] .
Experimental

General experimental procedures:
Silica gel (100-200, 200-300 mesh; Qingdao Marine Chemical Group Co.) and Sephadex LH-20 (GE Healthcare Co) were used for CC. 1D and 2D NMR spectra were obtained on Bruker AV-400 MHz and Bruker DRX-500MHz instruments with TMS as internal standard. MS were recorded with Agilent G3250AA and AutoSpec Premier P776 spectrometers.
Biological material and cultivation of actinomycete strain:
A microbial strain was isolated on modified ISP4-medium from Dendrobium chrysotoxum collected at Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences. Its 16S rRNA gene sequence showed that this strain is identical to that of Streptomyces scopuliridis RB72T (GenBank accession no. EF657884), and it was identified as Streptomyces sp. (YIM 66142). Streptomyces sp. YIM 66142 was cultivated on a 40 L scale using 1L Erlenmeyer flasks containing 250 mL of the fermentation medium (soybean powder 0.3%, glucose 2%, yeast extract 0.2% starch 0.5%，peptone 0.2%, NaCl 0.4%, K 2 HPO 4 0.05%, MgSO 4 0.05%，CaCO 3 0.2%, pH7.2) and the seed medium (yeast extract 0.4%, glucose 0.4%, malt extract 0.5%, decavitamin, alanine 0.03%, pH 7.2) at 28°C for 5 days on a rotary skaker (300 rpm).
Extraction and isolation of compounds:
The fermented whole broth (40 L) was centrifuged to separate the mycelia from fermentation broth. The fermented broth was extracted 3 times with ethyl acetate, and the solvent was removed to obtain the EtOAc extract (29.1 g) under vacuum. The mycelia were also extracted 3 times with acetone, and the solvent removed under vacuum to obtain the extract (8.0 g). The two extracts were combined, suspended in 500 mL H 2 O, extracted 3 times with equal volumes of EtOAc, and then the solvent removed under vacuum to obtain the total extract (13 g). This was separated over a silica gel column to yield 7 fractions (Fr.1-Fr.7) by eluting stepwise with a CHCl 3 /MeOH gradient from CHCl 3 to MeOH. Fr. 2 (2.7 g, eluted with CHCl 3 ) was separated by repeated CC on silica gel and Sephadex LH-20 to afford 2 (5.1 mg). Fr.5 (1.2 g, eluted with CHCl 3 :MeOH; 20:1) was separated by repeated CC on silica gel and Sephadex LH-20 to afford compound 1 (3.8mg).
Cytotoxicity assays assays:
The cytotoxicities of 1 were investigated at concentrations up to 40 μM by the MTS method. Briefly, cells were seeded in 96-well plates at a density of 5.010 3 to 110 4 cells/well. Cells were treated with different concentrations of compound 1 for 48 h, following incubation with MTS solution for 4 h. The absorbance was measured using a microplate reader (Bio-Rad 680) at a wavelength of 490 nm. Cisplatin was used as a positive control, generating IC 50 values of 1.32, 4.12, 8.68, 13.96, and 14.81 μM against human promyelocytic leukemia HL-60, human hepatoma SMMC-7721, non-small cell lung cancer A-549, breast cancer MCF-7, and human colorectal carcinoma SW480 cells lines, respectively. However, no obvious cytotoxicity of 1 against HL-60, SMMC-7721, A-549, MCF-7, and SW480 cells lines was shown.
Antimicrobial assay: Antibacterial assays of Streptomyces sp. YIM 66142 on fermentation broth were performed using the agar well diffusion method. Wells 4 mm in diameter were punched into plates freshly inoculated with F. avenaceum and filled with 200 μL of 6 day old culture media. The plates were incubated at 37°C for 24 h, and the inhibition zones of F. avenaceum growth around each well were measured. On average, a 12 mm inhibition zone was produced. 
